ICWA Weekly News 3-13-24
John Stockton leads plaintiffs in suit against AG Ferguson and WMC; Epoch Times calls out vaccine bill in WA; RSV shots for adults not as safe as claimed; DOH minimizes post-vaccine heart damage
In this issue:
Free speech complaint filed in Federal Court by John Stockton and Washington doctors against WMC and AG Ferguson
Breaking: Epoch Times exposes SB 5982 vaccine definition change; ICWA interviewed
“Serious” Events in Washington Following the Abrysvo and Arexvy RSV Shots
Washington DOH Does Damage Control on Myocarditis Following COVID-19 Shots
Radio Show Links and Notes
Upcoming events: Olympia, Seattle and Spokane
Free speech complaint filed in Federal Court by John Stockton and Washington doctors against WMC and AG Ferguson
Washingtonians organize to stop the WMC from silencing doctors’ speech.
On Thursday March 7th, Children’s Health Defense (CHD) lawyers, including Robert F. Kennedy Jr., filed a complaint in Federal Court, Eastern District of Washington, against Attorney General Bob Ferguson and the Washington Medical Commission for silencing doctors. Stockton v Ferguson plaintiffs include NBA legend John Stockton of Spokane, Dr. Richard Eggleston, Dr. Thomas Siler, Dr. Dan Moynihan, and many as-yet unnamed plaintiffs who have all experienced the effects of misplaced WMC policies.
The complaint rests on the precedent that the public should have access to ‘soapbox speech,’ and that previous legal decisions on professional soapbox speech have stated that it is fully protected by the First Amendment. Actions by the WMC have directly silenced doctors in Washington who spoke out with valid concerns and opinions, which indirectly silenced many other doctors.
Lead attorney Rick Jaffe has stated that this case will likely be decided by the Supreme Court.
The complete article announcing the case was published by The Defender on Monday March 11, and is republished here on the Washington chapter site.
Plaintiff John Stockton and lawyer Rick Jaffe explain it all on Good Morning CHD March 13. Another interview is expected to be aired on Fox & Friends First on March 14.
Breaking: ICWA consulted by Epoch Times to expose SB 5982 vaccine definition change
Published today, the Epoch Times shines light on the Washington state legislature’s passage of SB 5982 which updated the vaccine definition for the Washington Vaccine Association.
IN-DEPTH: Washington State Legislation ‘Updates’ Definition of Vaccine to Include ’New Technologies’
The long-form article details how the bill was passed and quotes ICWA director Lisa Templeton and other ICWA members. We hope the visibility will stop public health agencies from acting outside the law and remind them that the public is watching their activities closely.
“Serious” Events in Washington Following the Abrysvo and Arexvy RSV Shots
In other news that runs contrary to the state’s unquestioning devotion to CDC recommendations, The Defender published a March 5 article with the long title “34 Deaths 302 Serious Injuries: RSV Vaccines Aren’t Even a Year Old, But Some Experts Say It’s Time to Pull Them from the Market.”
Newly approved vaccines for respiratory syncytial virus have been linked to deaths and serious injuries and, most recently, to Guillain-Barré syndrome, but U.S. health officials continue to recommend them as “safe and effective.”
As we often do in our ICWA Weekly News, the Defender article digs into VAERS data where there were 302 “serious” events following the RSV shots. Nearly 50% of reports occurred in the 65-to-79 year old age range.
The U.S. Food and Drug Administration (FDA) approved Pfizer’s Abrysvo and GSK’s Arexvy RSV vaccines for adults ages 60 and older — but not for children or babies. Abrysvo is also approved for pregnant women, targeting RSV prevention in babies. The FDA approved Abrysvo and Arexvy in May 2023.
Separately, monoclonal antibody shots for RSV (nirsevimab) are recommended for babies and have their own safety issues.
In The Defender article on adult RSV shots, Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense, said “Thirty-four deaths in ten months should be sufficient to pull the RSV vaccines from the market. But the FDA will not do that — nor will there be full investigations regarding these deaths.”
For Washington state, VAERS data only shows 106 adverse events after RSV products, mostly in older age groups. Thankfully, none of the thirty-four deaths have occurred here. Ten Washington reports are listed as “serious.”
Washington’s first “serious” recorded event took place on October 4 and was related to GSK’s Arexvy shot. All reports are listed here for easy reference, including the notable submitted write-ups, where all seem to be from health providers or office staff.
VAERS ID: 2691021
Adverse event for a 75-year-old female, whose onset took place a day after the shot:
Submitted write-up to VAERS: HYPERTENSION - BP 170/125, Patient admitted for 2 days, changed beta-blocker from metoprolol to carvedilol.
VAERS ID: 2700443
Adverse event for a 64-year-old female was recorded last October 24. The first two sentences of the submitted write-up seems the opposite of safe:
Community acquired pneumonia; Shortness of Breath; Influenza A; This serious case was reported by a physician via sales rep and described the occurrence of community acquired pneumonia in a 64-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On 17-SEP-2023, the patient received the 1st dose of Arexvy. In SEP-2023, less than 2 weeks after receiving Arexvy, the patient experienced shortness of breath (Verbatim: Shortness of Breath) (serious criteria hospitalization) and influenza a virus infection (Verbatim: Influenza A) (serious criteria hospitalization).
VAERS ID: 2720084
Adverse event for a 60-year-old male was recorded December 1, 2023, with onset of symptoms a day after the Arexvy shot. He experienced numbness and weakness in the right arm and was unable to squeeze his right hand. Later, he experienced a low-grade headache, and then some spots in his vision. These series of events lasted for lasted for one hour. The submitted write-up provides the primary diagnosis:
Transient Ischemic Attack (TIA) Treatment: Performed CTscan, MRI and Electrocardiogram. Including a full blood work-up. Patient was administered clopidogreL 75 mg tablet (Plavix) to reduce the future strokes. Outcome: Patient has no symptoms at time of discharge.
VAERS ID: 2743570
Adverse event for a 74-year-old male was recorded last February 3. The onset began five days after the shot.
Submitted write-up: LOWER EXTREMITY VENOUS: EVIDENCE OF EXTENSIVE DVT IN THE PVT, PERONEAL VEINS AND GASTROCNEMIUS VEINS EXTENDING INTO THE POPLITEAL AND FEMORAL VEIN UP TO THE PROXIMAL THIGH. THESE VEINS ARE INCOMPRESSIBLE WITH NO FLOW SEEN. THIS WAS SUBJECT TO HOSPITALISATION TO TREAT THE BLOOD CLOT AND ELIQUIS TREATMENT 20 MG OVER A PERIOD OF 9 DAYS, THEN 10 MG STARTING JANUARY 12, 2024. I WAS ALSO UNDER IV ANTIBIOTICS TO TREAT PNEUMONIA DURING THE HOSPITALISATION AND WITH A TREATMENT OVER 7 DAYS WITH AMOX PILLS.
VAERS ID: 2746455
Adverse event for a 67-year-old male was recorded last February 13. The onset began on the same day as the shot where the patient went to the hospital because he had trouble breathing.
VAERS ID: 2715267
Adverse event for a 71-year-old female was recorded last November 17.
Submitted write-up: Patient developed low grade fever, fatigue, aches 11/14/23. Morning of 11/15/23 acutely confused, vomited multiple times. Sent to ED 11/15/23: CT head, MRI brain negative, labs, UA, chest x-ray without abnormal finding. Viral pathogen testing negative. Dx with delirium, improved with time.
VAERS ID: 2728397
Adverse event for a 72-year-old male was recorded last December 28.
Submitted write-up: Write-up: increase pain for 3 weeks in upper left arm, followed by significant loss of arm mobility (unable to raise arm between 45 degrees). After one month of loss of mobility, slight improvement.
VAERS ID: 2736955
Adverse event for a 77-year-old female was recorded last January 22.
Submitted write-up: Patient developed acute encephalitis and required hospitalization and extensive workup and testing.
VAERS ID: 2743597
Adverse event for a 27-year-old female was recorded last February 4.
Submitted write-up: PPROM, Precipitous labor, and aged placenta
The tenth report based in Washington state did not list the RSV shot manufacturer, but Pfizer was mentioned. The write-up almost seems to be from the government VAERS office.
VAERS ID: 2719314
Adverse event for a 77-year-old male that was recorded by a patient’s physician last November 30. Comments do mention Pfizer. The write up is extensive, so we won’t reproduce it here. But it is noteworthy if you want to read all of it through the above link.
The last portion of the write-up seems unusual for a physician to write; it almost seems written by a Pfizer representative:
The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators as appropriate.
With these reports of adverse events, it only seems a matter of time until a death is reported in Washington to add to the national total currently at thirty four.
Washington DOH Does Damage Control on Myocarditis Following COVID-19 Shots
The first case of myocarditis following the COVID-19 shots recorded in Washington was of a 22-year-old male on April 16, 2021. April and May saw almost forty reports involved myocarditis after COVID-19 vaccination:
Select VAERS IDs:1221001, 1235437, 1239205, 1283185, 1284476
For the following month of June 2021, add on another twenty-nine cases of myocarditis following the COVID-19 shots, mostly in the younger age groups. Extrapolate this across the U.S., and you might think this would be a safety signal.
The numbers continued to climb to where Washington currently has 136 recorded cases of myocarditis following the COVID-19 shots.
While the number of myocarditis cases following the COVID-19 shots was climbing across the United States, the government health agency employees tried their best to ignore, suppress, or cover up the association, as revealed by The Epoch Times and Vaccine Reaction.
The Epoch Times published a comprehensive report of the timeline of activities related to myocarditis from COVID shots. Roman Balmakov (Facts Matter on Epoch TV [10 mins]) also described the feet-dragging delays and what looks like a cover-up based on what could be read in the heavily redacted emails from that time.
The timeline includes an almost proactive health advisory on May 21 by Seattle/King County and a May 24 Washington state rapid assessment of the significance of mycarditis reports. Most of the amazing timeline of events are listed here:
May 2021: 487 cases of myocarditis, pericarditis, or myopericarditis reported to VAERS, including four deaths.
May 2021: CDC forms a team to review medical records for reported cases of postvaccination myocarditis.
May 7, 2021: European Medicines Agency announces it has asked Pfizer for information on myocarditis after COVID-19 vaccination.
May 10, 2021: FDA authorizes Pfizer’s COVID-19 vaccine for children aged 12 to 15. It does not mention myocarditis.
May 11, 2021: CDC contractor raises concerns about post-vaccination myocarditis.
May 12, 2021: Dr. Walensky recommends Pfizer’s vaccine for virtually all children aged 12 to 15, based on advice from advisers.
May 13, 2021: The U.S. Department of Veterans Affairs detected a safety signal for the Pfizer-BioNTech vaccine and myocarditis, an email obtained by The Epoch Times shows.
May 13, 2021: Same officials discuss analyzing VAERS data for myocarditis using the Proportional Reporting Ratio in heavily redacted emails. The agency says the analysis didn’t actually start until 2022.
May 14, 2021: CDC’s National Center for Immunization and Respiratory Diseases sends out message on postvaccination myocarditis.
May 16, 2021: CDC official says in email, “we are hearing quite a lot about this now, and I don’t have a clear understanding of what is and has been being done.”
May 17, 2021: Dr. Shimabukuro speaks with American Academy of Pediatrics officials to “centralize our coordination” with outside groups.
May 17, 2021: Dr. Su says health care providers “aren’t reporting these cases to VAERS.”
May 17, 2021: Dr. Su says the “myocarditis thing” is “exploding.”
May 18, 2021: States across the U.S. publicly report cases of myocarditis following COVID-19 vaccination.
May 19, 2021: CDC tells state officials it has been “closely monitoring” myocarditis and pericarditis after COVID-19 vaccination and that cases “can be serious.”
May 20, 2021: CDC workgroup says, reporting on a May 17 review, there are “relatively few” reports of myocarditis after vaccination and that rates “have not differed from expected baseline rates.”
May 20, 2021: Oregon health officials ask healthcare providers to look out for cases of heart inflammation after vaccination.
May 20, 2021: CDC officials hold meeting with doctors from pediatric hospitals on myocarditis cases. Slides from the meeting were provided to The Epoch Times fully redacted.
May 21, 2021: CDC officials discuss a draft alert on COVID-19 vaccines and myocarditis, according to an email obtained by The Epoch Times. The alert was never sent.
May 21, 2021: Seattle/King County Public Health issues health advisory on myocarditis/pericarditis after COVID-19 vaccination.
May 24, 2021: Washington state finds 27 post-vaccination myocarditis/pericarditis cases in rapid assessment.
May 24, 2021: CDC workgroup acknowledges for the first time that the number of reports of postvaccination myocarditis to VAERS was higher than expected in those 16 to 24.
May 25, 2021: Dr. Paul Offit, an FDA adviser, says about myocarditis and COVID-19 vaccines, “there’s every reason to think this isn’t a problem.”
May 25, 2021: If CDC does not send the drafted alert, it’s because officials don’t want to cause panic, CDC official tells a vaccine manufacturer.
May 26, 2021: The New Zealand Medicines and Medical Devices Safety Authority says there’s a safety signal for myocarditis and COVID-19 vaccines.
May 27, 2021: CDC notes “increased reports” of postvaccination heart inflammation to VAERS. CDC says to keep vaccinating everyone eligible, or virtually all Americans 12 and older.
May 28, 2021: Case series of young, previously healthy males hospitalized with postvaccination myocarditis discloses hospitalizations happened as early as Jan. 30, 2021.
May 28, 2021: CDC says it is focusing on reported cases among those 30 and under.
June 2021: 752 cases of myocarditis, pericarditis, or myopericarditis reported to VAERS, including five deaths.
These events are more striking and tragic when we remember that VAERS suffers from an underreporting problem. Information uncovered in public records has confirmed there are also reporting delays. The October 4, 2023, ICWA Weekly News showed that during the May 2021 timeframe, CDC officials were told by Kathy Bay of the Washington Department of Health that nine post-vaccination myocarditis cases had not been reported to VAERS.
Three years after the COVID-19 shot rollout, the Washington Department of Health (DOH) has (sorta, kinda) finally acknowledged that the shots can cause myocarditis. The flyer we found on this matter is not readily available on a web page, nor listed as a frequently asked question. Rather, it is buried as a website file and can only be found by searching their site on myocarditis.
Myocarditis after COVID-19 Vaccination: What Parents and Young Adults Should Know (wa.gov)
The DOH flyer innocently states that this “association” is rare. Perhaps, they may want to tell that to the family and friends of the 136-plus myocarditis patients here in Washington.
The DOH flyer claims that myocarditis is more common after the COVID-19 infection than the COVID-19 shot. In our May 23, 2023 issue of ICWA Weekly News, we reviewed the one study cited by the DOH and found many questions and concerns, some of which we repeat here:
The study only looked at Major Adverse Cardiovascular Events (MACE) in patients with COVID-19 within the time range they define, so by design it does not assess risk of MACE following receipt of a COVID-19 vaccine outside of that infection scenario. The wordsmithed language of CDC’s letter implied otherwise. For decades, this has been the CDC’s modus operandi: their marketing communications do not match the science they cite.
Only incidences of MACE following first “index” COVID infections were included. “We also did not consider SARS-CoV-2 reinfections following index illness”.
If the study had included those vaccinated who were in that 14 day window, or who experienced reinfections, would the data point to an entirely different conclusion?
The authors wrote: “Overall, MACE was observed among 13,948 patients (0.7%): 12,733 cases occurred among nonvaccinated patients (0.7% of these patients), 160 in partially vaccinated patients (0.7%), and 1,055 in fully vaccinated patients (0.5%).” So, even with their excluding important windows of time and reinfections, even with their multiple adjustments and including a period when those most at risk of a MACE caught COVID, the difference between nonvaccinated and those they considered fully vaccinated was only .2%.
The DOH then makes the definitive statement that “There have been no deaths from myocarditis caused by the COVID-19 vaccination in the United States.” So, the DOH is bold enough to claim that of the 441 reports of myocarditis deaths following the COVID-19 shots in VAERS none of them were caused by those jabs.
Somehow, the DOH overlooked the following VAERS November 23, 2023 report that said “The reported cause of death was myocarditis” and “The hospital determined that the cause of death was myocarditis.”
VAERS ID: 2717074
Write-up: Myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (Myocarditis) in a male patient of an unknown age who received mRNA-1273 (SPIKEVAX) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jun-2021, the patient received dose of mRNA-1273 (SPIKEVAX) (unknown route) 1 dosage form. On 09-Jul-2021, after starting mRNA-1273 (SPIKEVAX), the patient experienced MYOCARDITIS (Myocarditis) (seriousness criteria death and medically significant). The patient died on 09-Jul-2021. The reported cause of death was Myocarditis. It is unknown if an autopsy was performed. No concomitant medication was reported. It was reported that the patient received the first dose of Modema vaccine on 18-Jun-2021, and patient had no reaction at that time. But unexpectedly, the reaction appeared 3 weeks later. On 09-Jul-2021, patient fainted in the workplace while going to work. This time he fainted developed syncope and never woke up. The hospital determined that the cause of death was myocarditis.
The DOH was also bold enough to infer that the two myocarditis deaths here in Washington following the COVID-19 jabs were definitively not caused by those jabs.
VAERS ID: 1499689
A 35-year-old male who took the first dose of Pfizer on May 11, 2021. His onset began twenty-three days later. The date of the death was not given. The report was submitted on July 24, 2021. The submitted write-up mentions other possibilities besides myocarditis: ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems. The end of the write-up suggests that a heart attack could have led to a bad fall: Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?) Awaiting additional physician notes/imaging reports.
VAERS ID: 2057959
A 62-year-old male whose onset began sixty-nine days later after taking his second dose of Moderna on February 1, 2021. He died on April 11, 2021. The report was recorded on January 23, 2022, showing it took nine months after his death for the report to surface on VAERS, reflecting The Epoch Times article on the backlog of recording.
In the submitted write-up, his daughter reports (emphasis added):
his chest pain and abdominal discomfort began on April 11, 2021…The CT scan showed aortic dissection, after which he was given nitroglycerin via IV and "gastric cocktail" oral solution…They barely got him into an ambulance, and after leaving the parking lot, he went into cardiac arrest. The daughter then wrote the following: Spouse had to make choice to stop CPR as his aortic dissection was now such a low chance of success and due to lack of oxygen, per MD, less then 2% chance of neurological recovery. He had an autopsy performed which showed aortic dissection, massive cardiac arrest as well as myocarditis and enlargement of the heart, fluid around the heart. All data provided here is either from my first-hand witnessing in the ER (I am a trained Medic) or the actual autopsy report and ER medical records my stepmom & I obtained after his death. He was pronounced dead at 9PM on April 11th, 2021; approx 3 hours after admittance.
The DOH also makes the claim that most myocarditis cases are mild.
They might be borrowing language from a 2015 write-up from the National Organization for Rare Disorders (NORD) that states:
Most cases of myocarditis are mild and improve with standard medical therapy directed at improving heart function or correcting abnormal heart rhythms. In a minority of cases the symptoms do not improve or become recurrent. In these circumstances referral to a medical center with expertise in myocarditis management is useful. The evaluation and management of chronic or recurrent myocarditis is not standardized.
However, the January 24, 2024 a peer-reviewed study published in the journal Cureus said that there’s much more to myocarditis. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign, notably authored by M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch, and Peter A. McCullough, has now been retracted.
The authors wrote:
In adolescent males, however, myocarditis can have a mild outward clinical appearance yet result in severe cardiac fibrosis (scarring), with permanent damage to the heart muscle. Such damage can eventually lead to congestive heart failure and death many years later. The registrational trials were insufficient for detecting these long-range hazards, most of which only became evident after 2.5 years of follow-up observation and over a billion mRNA injections.
What are we left to think except that the Washington Department of Health lies in its public relations flyers.
March 8 Informed Life Radio—Links and Notes
Health Hour: Do You Sit Too Much?
Guest: Sharon Landrum
How can a sedentary lifestyle impact your health? Sharon Landrum, experienced nerve damage and pain from years of sitting at work. In this episode, viewers learn the details of Sharon’s condition as well as hear about therapies for healing and preventative measures for the long-term.
Liberty Hour: Guardrail Guy: One Man Making a Difference
Guests: Lisa Templeton, Steve Eimers
Hear about the Washington Vaccine Association from ICWA Director Lisa Templeton and how to monitor their proceedings.
Washington Vaccine Association - Board and Committee Meeting Documents
When Steve Eimers’ daughter was killed by a highway guardrail in 2016, his life forever changed. In his pursuit for answers, he learned that America is riddled with dysfunctional and failing guardrails that claim more than 1,000 lives a year. His work to improve guardrail safety and eradicate fraud has saved countless lives. Additionally, he’s established a recording system to record traffic cam videos in several states and his footage has captured drive-by shootings, drunk driving collisions, and recently a plane crash, helping authorities with their investigations.
Tesla Crash Test FAILURE: University of Nebraska Explanation [8 Mins]
Upcoming Events
Announcing the Second Meeting of the INW Association for the Pursuit of Knowledge
Update on Transgender Medicine: What You Should Know, with Alfonso Oliva, MD FACS
Tuesday, March 26, 2024, 7:00 PM - 8:45 PM
The Multi-Purpose Room, Hutton Elementary School, 908 E 24th Ave., Spokane
CHD Bus Stops “The People’s Study” in Washington.
Book an Interview
April 16 - The People’s Study Bus in Olympia – 12-2 PM Lunch with Legislators.
April 17 - The People’s Study Bus in Seattle, Westlake Park, 9 AM - 4 PM. The Refusers band at noon. Speakers Brian Hooker, PhD, and Dr. Paul Thomas at 1 PM.
April 19 - The People’s Study Bus in Spokane. 8 AM - 5 PM. Get your tickets for the speaking event 4 PM - 6 PM. Dr. Scott Jensen, Dr. Paul Thomas, Dr. Kelly Victory. MC: Shawn Needham.
Also in Spokane on April 18-20:
April 18-20 WSRP State Convention, Spokane Convention Center, find us at the ICWA table.
Medical Freedom Northwest April 20 retreat in Spokane; continuing ed credits for providers: Kelly Victory, Scott Jensen, Mary Talley Bowden, Kim Overton.
And after all that reading, your reward – a Meme o’ the Week.
If that was too grim, here’s one more to maybe lighten the mood.
Thanks for your support. See you next week.
Oh no, those memes! 😬
Thanks for bringing us these Washington State-focused stories!
Informed Life Radio is a two hour radio show that airs every Friday from 3pm-5pm from a local Seattle station, KKNW. It then is also posted as a podcast. There are some amazing guests and great topics.
https://podcasts.apple.com/us/podcast/informed-life-radio/id1526360922